Valuation: Diaceutics PLC

Market Cap 11Cr 15Cr 13Cr 12Cr 21Cr 1.4TCr 21Cr 141.34Cr 55Cr 689.94Cr 55Cr 54Cr 2.39TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10Cr 14Cr 12Cr 11Cr 19Cr 1.3TCr 19Cr 131.37Cr 51Cr 641.24Cr 51Cr 50Cr 2.22TCr EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.72x
Free-Float
71.95%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
3 months+19.76%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.34
Extreme 1.338
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 55 01/10/2023
Chairman 65 01/10/2024
Director/Board Member 42 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 15Cr
-15.02%+5.66%+259.99%+891.39% 4.81TCr
-0.72%+2.19% - - 657.6Cr
-3.74%-0.57%+2.93%+19.21% 329.57Cr
+5.86%+11.62% - - 352.98Cr
-7.13%+3.24%+8.73%+101.69% 308.36Cr
-9.86%-7.15%-46.07%+30.14% 118.82Cr
-1.54%+1.43%-18.86%-41.79% 127.94Cr
-2.78%+1.24%-37.15%-46.09% 123.05Cr
Average -2.40%+0.83%+28.26%+159.09% 853.26Cr
Weighted average by Cap. +0.03%+4.56%+213.42%+742.13%

Financials

2026 *2027 *
Net sales 4.7Cr 6.27Cr 5.51Cr 5.12Cr 8.83Cr 603.9Cr 8.97Cr 61Cr 24Cr 296.9Cr 24Cr 23Cr 1.03TCr 5.63Cr 7.51Cr 6.6Cr 6.14Cr 11Cr 723.54Cr 11Cr 73Cr 28Cr 355.72Cr 28Cr 28Cr 1.23TCr
Net income -11L -14.68L -12.89L -11.99L -20.67L -14Cr -20.99L -1.42Cr -55.61L -6.95Cr -55.09L -53.91L -24Cr 15L 20.01L 17.58L 16.35L 28.18L 19Cr 28.62L 1.94Cr 75.84L 9.48Cr 75.13L 73.51L 33Cr
Net Debt -77.1L -1.03Cr -90.35L -84.02L -1.45Cr -99Cr -1.47Cr -9.98Cr -3.9Cr -49Cr -3.86Cr -3.78Cr -168.39Cr -1.21Cr -1.62Cr -1.42Cr -1.32Cr -2.28Cr -155.92Cr -2.32Cr -16Cr -6.14Cr -77Cr -6.08Cr -5.95Cr -265.04Cr
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.290GBP
Average target price
2.130GBP
Spread / Average Target
+65.12%

Quarterly revenue - Rate of surprise